Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer data have been reported by P. Vestergaard and co-authors
August 14th, 2008
According to a study from Aarhus, Denmark, "We studied risk of fractures among women who had used tamoxifen or aromatase inhibitors compared to nonusers in a case-control study. There were 64,548 fracture cases and 193,641 age- and gender-matched controls." "Adjustment was made for comorbidity, social factors, and use of orther drugs. Use of tamoxifen in general was not associated with any significant change in the risk of any fracture, wrist fractures, and spine fractures. A significantly decreasing relative risk of fractures was seen with increasing dose, although the risk never declined statistically significantly below that in nonusers. An increased risk of hip...
Source: Women's Health Weekly (2008-08-14)
|
